Calcium in PDB 1d7x: Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
Enzymatic activity of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
All present enzymatic activity of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.:
3.4.24.17;
Protein crystallography data
The structure of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor., PDB code: 1d7x
was solved by
M.Y.Cheng,
M.G.Natchus,
B.De,
N.G.Almstead,
S.Pikul,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
10.00 /
2.00
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
37.850,
78.220,
104.740,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
26.2 /
22.7
|
Other elements in 1d7x:
The structure of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor. also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
(pdb code 1d7x). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 6 binding sites of Calcium where determined in the
Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor., PDB code: 1d7x:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
Calcium binding site 1 out
of 6 in 1d7x
Go back to
Calcium Binding Sites List in 1d7x
Calcium binding site 1 out
of 6 in the Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca303
b:6.1
occ:1.00
|
OE2
|
A:GLU184
|
2.3
|
8.9
|
1.0
|
O
|
A:GLY159
|
2.3
|
8.2
|
1.0
|
OD2
|
A:ASP181
|
2.3
|
7.0
|
1.0
|
O
|
A:VAL163
|
2.4
|
2.1
|
1.0
|
OD1
|
A:ASP158
|
2.5
|
2.0
|
1.0
|
O
|
A:GLY161
|
2.5
|
5.8
|
1.0
|
CG
|
A:ASP181
|
3.3
|
4.2
|
1.0
|
CD
|
A:GLU184
|
3.4
|
6.5
|
1.0
|
C
|
A:GLY159
|
3.5
|
6.4
|
1.0
|
C
|
A:VAL163
|
3.6
|
2.0
|
1.0
|
CG
|
A:ASP158
|
3.6
|
2.8
|
1.0
|
C
|
A:GLY161
|
3.6
|
3.3
|
1.0
|
CB
|
A:ASP181
|
3.9
|
2.0
|
1.0
|
N
|
A:GLY161
|
3.9
|
3.3
|
1.0
|
OE1
|
A:GLU184
|
4.1
|
8.1
|
1.0
|
C
|
A:PRO160
|
4.1
|
7.0
|
1.0
|
OD2
|
A:ASP158
|
4.2
|
4.4
|
1.0
|
C
|
A:ASP158
|
4.2
|
7.6
|
1.0
|
N
|
A:VAL163
|
4.2
|
3.1
|
1.0
|
N
|
A:GLY159
|
4.2
|
4.1
|
1.0
|
OD1
|
A:ASP181
|
4.2
|
4.3
|
1.0
|
CA
|
A:GLY161
|
4.3
|
2.0
|
1.0
|
N
|
A:ASP158
|
4.3
|
7.7
|
1.0
|
CA
|
A:VAL163
|
4.4
|
3.5
|
1.0
|
O
|
A:HOH452
|
4.4
|
5.7
|
1.0
|
CG
|
A:GLU184
|
4.4
|
6.7
|
1.0
|
N
|
A:PRO160
|
4.4
|
8.5
|
1.0
|
O
|
A:ASP158
|
4.4
|
7.6
|
1.0
|
CA
|
A:GLY159
|
4.5
|
4.9
|
1.0
|
C
|
A:ASN162
|
4.5
|
4.9
|
1.0
|
CA
|
A:PRO160
|
4.5
|
8.2
|
1.0
|
N
|
A:LEU164
|
4.6
|
3.2
|
1.0
|
O
|
A:PRO160
|
4.6
|
7.2
|
1.0
|
CA
|
A:ASP158
|
4.6
|
6.2
|
1.0
|
CB
|
A:VAL163
|
4.7
|
4.1
|
1.0
|
CB
|
A:ASP158
|
4.7
|
3.8
|
1.0
|
O
|
A:HOH492
|
4.7
|
11.8
|
1.0
|
N
|
A:ASN162
|
4.7
|
4.6
|
1.0
|
CA
|
A:LEU164
|
4.7
|
3.2
|
1.0
|
O
|
A:ASN162
|
4.8
|
6.4
|
1.0
|
|
Calcium binding site 2 out
of 6 in 1d7x
Go back to
Calcium Binding Sites List in 1d7x
Calcium binding site 2 out
of 6 in the Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca304
b:12.2
occ:1.00
|
O
|
A:HOH403
|
2.0
|
19.3
|
1.0
|
O
|
A:ASP182
|
2.2
|
5.4
|
1.0
|
O
|
A:HOH496
|
2.4
|
14.1
|
1.0
|
OD2
|
A:ASP107
|
2.4
|
9.4
|
1.0
|
OD1
|
A:ASP182
|
2.5
|
4.8
|
1.0
|
OD1
|
A:ASP107
|
2.6
|
6.4
|
1.0
|
O
|
A:GLU184
|
2.6
|
4.2
|
1.0
|
CG
|
A:ASP107
|
2.8
|
7.1
|
1.0
|
C
|
A:ASP182
|
3.3
|
5.2
|
1.0
|
CG
|
A:ASP182
|
3.5
|
3.3
|
1.0
|
C
|
A:GLU184
|
3.7
|
3.9
|
1.0
|
CA
|
A:ASP182
|
3.8
|
2.8
|
1.0
|
CB
|
A:ASP182
|
4.0
|
2.0
|
1.0
|
OG1
|
A:THR105
|
4.0
|
5.5
|
1.0
|
CA
|
A:GLN185
|
4.3
|
5.7
|
1.0
|
N
|
A:GLU184
|
4.3
|
7.7
|
1.0
|
CB
|
A:ASP107
|
4.3
|
5.5
|
1.0
|
CD1
|
A:TRP186
|
4.4
|
4.1
|
1.0
|
N
|
A:ASP183
|
4.4
|
6.0
|
1.0
|
O
|
A:HOH449
|
4.4
|
34.6
|
1.0
|
N
|
A:GLN185
|
4.4
|
5.0
|
1.0
|
OD2
|
A:ASP182
|
4.5
|
4.5
|
1.0
|
C
|
A:ASP183
|
4.6
|
7.1
|
1.0
|
OE1
|
A:GLN185
|
4.6
|
9.4
|
1.0
|
N
|
A:TRP186
|
4.7
|
7.1
|
1.0
|
CA
|
A:ASP183
|
4.7
|
7.0
|
1.0
|
NE1
|
A:TRP186
|
4.7
|
4.5
|
1.0
|
CA
|
A:GLU184
|
4.7
|
6.5
|
1.0
|
|
Calcium binding site 3 out
of 6 in 1d7x
Go back to
Calcium Binding Sites List in 1d7x
Calcium binding site 3 out
of 6 in the Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca305
b:8.2
occ:1.00
|
O
|
A:HOH470
|
2.1
|
13.7
|
1.0
|
O
|
A:HOH473
|
2.2
|
19.6
|
1.0
|
O
|
A:GLY173
|
2.2
|
7.6
|
1.0
|
O
|
A:ASP141
|
2.4
|
4.8
|
1.0
|
O
|
A:ASN175
|
2.4
|
6.1
|
1.0
|
OD1
|
A:ASP177
|
2.6
|
2.0
|
1.0
|
C
|
A:GLY173
|
3.4
|
8.3
|
1.0
|
CG
|
A:ASP177
|
3.5
|
2.9
|
1.0
|
C
|
A:ASP141
|
3.5
|
2.0
|
1.0
|
C
|
A:ASN175
|
3.6
|
6.3
|
1.0
|
OD2
|
A:ASP177
|
3.8
|
2.0
|
1.0
|
N
|
A:GLY173
|
3.9
|
12.2
|
1.0
|
O
|
A:ALA140
|
4.0
|
2.0
|
1.0
|
C
|
A:ILE174
|
4.1
|
5.6
|
1.0
|
N
|
A:ASN175
|
4.1
|
7.0
|
1.0
|
N
|
A:ASP177
|
4.2
|
6.1
|
1.0
|
CA
|
A:GLY173
|
4.2
|
11.2
|
1.0
|
CA
|
A:ASP141
|
4.2
|
3.5
|
1.0
|
O
|
A:GLY171
|
4.3
|
10.5
|
1.0
|
C
|
A:PRO172
|
4.3
|
14.4
|
1.0
|
N
|
A:ILE174
|
4.3
|
10.2
|
1.0
|
O
|
A:ILE174
|
4.4
|
4.8
|
1.0
|
C
|
A:GLY176
|
4.4
|
3.0
|
1.0
|
CA
|
A:ILE174
|
4.4
|
8.3
|
1.0
|
CA
|
A:GLY176
|
4.5
|
3.4
|
1.0
|
N
|
A:GLY176
|
4.5
|
5.7
|
1.0
|
CA
|
A:ASN175
|
4.5
|
7.2
|
1.0
|
N
|
A:ILE142
|
4.5
|
3.4
|
1.0
|
O
|
A:PRO172
|
4.6
|
13.4
|
1.0
|
O
|
A:HOH427
|
4.7
|
19.1
|
1.0
|
CB
|
A:ASP177
|
4.7
|
2.0
|
1.0
|
CG
|
A:MET143
|
4.7
|
4.3
|
1.0
|
N
|
A:MET143
|
4.7
|
4.5
|
1.0
|
O
|
A:HOH414
|
4.8
|
5.0
|
1.0
|
CA
|
A:ILE142
|
4.8
|
2.9
|
1.0
|
CA
|
A:ASP177
|
4.8
|
3.5
|
1.0
|
O
|
A:HOH447
|
4.9
|
11.2
|
1.0
|
C
|
A:ALA140
|
5.0
|
2.0
|
1.0
|
CH2
|
A:TRP92
|
5.0
|
11.2
|
1.0
|
|
Calcium binding site 4 out
of 6 in 1d7x
Go back to
Calcium Binding Sites List in 1d7x
Calcium binding site 4 out
of 6 in the Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca803
b:7.9
occ:1.00
|
O
|
B:GLY661
|
2.2
|
11.2
|
1.0
|
O
|
B:GLY659
|
2.3
|
17.1
|
1.0
|
OD1
|
B:ASP658
|
2.3
|
12.2
|
1.0
|
O
|
B:VAL663
|
2.4
|
8.4
|
1.0
|
OE2
|
B:GLU684
|
2.4
|
11.0
|
1.0
|
OD2
|
B:ASP681
|
2.5
|
4.8
|
1.0
|
C
|
B:GLY661
|
3.3
|
10.9
|
1.0
|
CG
|
B:ASP658
|
3.5
|
11.3
|
1.0
|
C
|
B:GLY659
|
3.5
|
14.6
|
1.0
|
CG
|
B:ASP681
|
3.5
|
4.6
|
1.0
|
C
|
B:VAL663
|
3.5
|
7.6
|
1.0
|
CD
|
B:GLU684
|
3.6
|
10.3
|
1.0
|
N
|
B:GLY661
|
3.7
|
11.8
|
1.0
|
C
|
B:PRO660
|
3.9
|
14.4
|
1.0
|
CA
|
B:GLY661
|
4.0
|
10.7
|
1.0
|
N
|
B:VAL663
|
4.1
|
9.9
|
1.0
|
OD2
|
B:ASP658
|
4.1
|
11.3
|
1.0
|
N
|
B:GLY659
|
4.2
|
15.2
|
1.0
|
CB
|
B:ASP681
|
4.2
|
6.0
|
1.0
|
C
|
B:ASP658
|
4.2
|
15.3
|
1.0
|
C
|
B:ASN662
|
4.2
|
9.9
|
1.0
|
CA
|
B:VAL663
|
4.3
|
6.7
|
1.0
|
O
|
B:PRO660
|
4.3
|
15.3
|
1.0
|
OE1
|
B:GLU684
|
4.3
|
13.5
|
1.0
|
O
|
B:HOH110
|
4.4
|
16.6
|
1.0
|
N
|
B:PRO660
|
4.4
|
15.3
|
1.0
|
N
|
B:ASP658
|
4.4
|
12.3
|
1.0
|
CA
|
B:PRO660
|
4.4
|
14.8
|
1.0
|
N
|
B:ASN662
|
4.4
|
9.6
|
1.0
|
OD1
|
B:ASP681
|
4.4
|
7.0
|
1.0
|
CA
|
B:GLY659
|
4.4
|
15.5
|
1.0
|
O
|
B:ASN662
|
4.5
|
12.3
|
1.0
|
O
|
B:ASP658
|
4.5
|
18.8
|
1.0
|
CA
|
B:ASP658
|
4.5
|
13.3
|
1.0
|
CG
|
B:GLU684
|
4.6
|
7.0
|
1.0
|
N
|
B:LEU664
|
4.6
|
7.7
|
1.0
|
CB
|
B:ASP658
|
4.6
|
13.3
|
1.0
|
CA
|
B:ASN662
|
4.7
|
8.8
|
1.0
|
CB
|
B:VAL663
|
4.7
|
3.4
|
1.0
|
CA
|
B:LEU664
|
4.8
|
8.0
|
1.0
|
CB
|
B:ASN662
|
4.8
|
9.0
|
1.0
|
|
Calcium binding site 5 out
of 6 in 1d7x
Go back to
Calcium Binding Sites List in 1d7x
Calcium binding site 5 out
of 6 in the Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca804
b:9.2
occ:1.00
|
O
|
B:ASP682
|
2.2
|
10.5
|
1.0
|
O
|
B:HOH14
|
2.4
|
12.2
|
1.0
|
O
|
B:GLU684
|
2.5
|
8.0
|
1.0
|
OD1
|
B:ASP682
|
2.5
|
6.7
|
1.0
|
OD2
|
B:ASP607
|
2.5
|
6.6
|
1.0
|
OD1
|
B:ASP607
|
2.5
|
8.8
|
1.0
|
CG
|
B:ASP607
|
2.9
|
5.1
|
1.0
|
C
|
B:ASP682
|
3.2
|
7.6
|
1.0
|
CG
|
B:ASP682
|
3.5
|
4.4
|
1.0
|
C
|
B:GLU684
|
3.6
|
6.9
|
1.0
|
CA
|
B:ASP682
|
3.8
|
6.3
|
1.0
|
CB
|
B:ASP682
|
4.0
|
3.0
|
1.0
|
OG1
|
B:THR605
|
4.1
|
6.7
|
1.0
|
N
|
B:GLU684
|
4.1
|
8.9
|
1.0
|
CD1
|
B:TRP686
|
4.2
|
3.0
|
1.0
|
N
|
B:ASP683
|
4.3
|
10.1
|
1.0
|
CA
|
B:GLN685
|
4.3
|
10.5
|
1.0
|
CB
|
B:ASP607
|
4.4
|
5.6
|
1.0
|
N
|
B:GLN685
|
4.4
|
8.1
|
1.0
|
C
|
B:ASP683
|
4.5
|
10.1
|
1.0
|
OD2
|
B:ASP682
|
4.5
|
4.2
|
1.0
|
CA
|
B:ASP683
|
4.6
|
7.1
|
1.0
|
CA
|
B:GLU684
|
4.6
|
8.3
|
1.0
|
N
|
B:TRP686
|
4.7
|
9.2
|
1.0
|
OE1
|
B:GLN685
|
4.8
|
27.3
|
1.0
|
NE1
|
B:TRP686
|
4.8
|
4.4
|
1.0
|
N
|
B:ASP607
|
5.0
|
9.3
|
1.0
|
|
Calcium binding site 6 out
of 6 in 1d7x
Go back to
Calcium Binding Sites List in 1d7x
Calcium binding site 6 out
of 6 in the Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of Crystal Structure of MMP3 Complexed with A Modified Proline Scaffold Based Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca805
b:8.8
occ:1.00
|
O
|
B:GLY673
|
2.2
|
12.7
|
1.0
|
O
|
B:HOH6
|
2.2
|
3.1
|
1.0
|
O
|
B:ASN675
|
2.3
|
6.5
|
1.0
|
O
|
B:ASP641
|
2.4
|
5.8
|
1.0
|
OD1
|
B:ASP677
|
2.6
|
5.8
|
1.0
|
C
|
B:GLY673
|
3.4
|
10.4
|
1.0
|
C
|
B:ASN675
|
3.5
|
6.4
|
1.0
|
C
|
B:ASP641
|
3.5
|
4.6
|
1.0
|
CG
|
B:ASP677
|
3.6
|
6.3
|
1.0
|
C
|
B:ILE674
|
4.0
|
8.0
|
1.0
|
O
|
B:HOH43
|
4.0
|
21.9
|
1.0
|
O
|
B:ILE674
|
4.1
|
10.8
|
1.0
|
OD2
|
B:ASP677
|
4.1
|
9.0
|
1.0
|
N
|
B:ASN675
|
4.1
|
7.2
|
1.0
|
O
|
B:ALA640
|
4.1
|
6.4
|
1.0
|
N
|
B:ASP677
|
4.2
|
7.4
|
1.0
|
CA
|
B:ASP641
|
4.2
|
4.2
|
1.0
|
N
|
B:GLY673
|
4.3
|
7.4
|
1.0
|
O
|
B:GLY671
|
4.3
|
8.1
|
1.0
|
CA
|
B:GLY673
|
4.3
|
8.2
|
1.0
|
N
|
B:ILE674
|
4.4
|
10.3
|
1.0
|
C
|
B:GLY676
|
4.4
|
6.5
|
1.0
|
CA
|
B:ASN675
|
4.4
|
7.2
|
1.0
|
CA
|
B:GLY676
|
4.4
|
4.8
|
1.0
|
N
|
B:GLY676
|
4.4
|
4.8
|
1.0
|
CA
|
B:ILE674
|
4.5
|
8.2
|
1.0
|
C
|
B:PRO672
|
4.6
|
10.3
|
1.0
|
N
|
B:ILE642
|
4.6
|
4.4
|
1.0
|
O
|
B:PRO672
|
4.7
|
11.2
|
1.0
|
O
|
B:HOH32
|
4.7
|
21.9
|
1.0
|
CB
|
B:ASP677
|
4.8
|
6.5
|
1.0
|
CH2
|
B:TRP592
|
4.8
|
6.9
|
1.0
|
N
|
B:MET643
|
4.8
|
6.4
|
1.0
|
CA
|
B:ILE642
|
4.8
|
6.3
|
1.0
|
CA
|
B:ASP677
|
4.8
|
7.2
|
1.0
|
O
|
B:HOH78
|
4.9
|
37.0
|
1.0
|
CG
|
B:MET643
|
4.9
|
7.0
|
1.0
|
|
Reference:
M.Cheng,
B.De,
N.G.Almstead,
S.Pikul,
M.E.Dowty,
C.R.Dietsch,
C.M.Dunaway,
F.Gu,
L.C.Hsieh,
M.J.Janusz,
Y.O.Taiwo,
M.G.Natchus,
T.Hudlicky,
M.Mandel.
Design, Synthesis, and Biological Evaluation of Matrix Metalloproteinase Inhibitors Derived From A Modified Proline Scaffold. J.Med.Chem. V. 42 5426 1999.
ISSN: ISSN 0022-2623
PubMed: 10639284
DOI: 10.1021/JM9904699
Page generated: Thu Jul 11 07:25:21 2024
|